Lyndra Therapeutics, Inc. — Form D

Lyndra Therapeutics, Inc. of WATERTOWN, MA, a company, filed a Form D exempt-offering notice with the SEC on 2023-06-07. The offering totals $179.3M, of which $20.4M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (35)

Showing 25 of 35 people.

NameRoleLocation
Zafi AvnurDirectorWatertown, MA
Doug Giovanni DachilleDirectorWatertown, MA
Patricia HurterDirectorWatertown, MA
Robert Giovanni LangerDirectorWatertown, MA
Helene Giovanni MadonickDirectorWatertown, MA
Jillian Moo-YoungDirectorWatertown, MA
Catherine Giovanni ReynoldsDirectorWatertown, MA
Ashish Giovanni SinghDirectorWatertown, MA
Jessica Giovanni BallingerExecutive OfficerWatertown, MA
Patricia HurterExecutive OfficerWatertown, MA
Amy SchulmanDirectorCambridge, MA
Robert LangerDirectorPittsburgh, PA
Catherine ReynoldsDirectorDurham, NC
Zafi S AvnurDirectorWatertown, MA
Ashish S SinghDirectorWatertown, MA
Jessica BallingerDirectorWatertown, MA
Jessica BallingerExecutive OfficerWatertown, MA
Doug S DachilleDirectorWatertown, MA
Patricia S HurterDirectorWatertown, MA
Catherine S ReynoldsDirectorWatertown, MA
Helene S MadonickDirectorWatertown, MA
Carlo Giovanni TraversoDirectorWatertown, MA
Amy W SchulmanDirectorWatertown, MA
Amy W SchulmanExecutive OfficerWatertown, MA
Robert S LangerDirectorNewton, MA

Other filings by this issuer (7)

FiledFormOfferingSold
2023-12-29D$206.1M$122.7M
2021-06-23D$65.0M$60.5M
2019-01-28D$60.9M$55.2M
2017-04-19D/A$23.1M$23.1M
2017-03-07D/A$20.1M$20.1M
2017-02-10D/A$17.1M$17.1M
2016-07-13D$5.9M$5.9M

More